Literature DB >> 26076041

IGF-1 Receptor Insufficiency Leads to Age-Dependent Attenuation of Osteoblast Differentiation.

Lee-Chuan C Yeh1, Matthew Wilkerson1, John C Lee1, Martin L Adamo1.   

Abstract

In the current study, we determined the effects of IGF-1 receptor haploinsufficiency on osteoblast differentiation and bone formation throughout the lifespan. Bone mineral density was significantly decreased in femurs of male and female Igf1r(+/-) mice compared with wild-type mice. mRNA expression of osteoblast differentiation markers was significantly decreased in femurs and calvariae from Igf1r(+/-) mice compared with cells from wild-type mice. Bone morphogenetic protein-7-induced ectopic bone in Igf1r(+/-) mice was significantly smaller with fewer osteoblasts but more lipid droplets and had reduced expression of osteoblast differentiation markers compared with wild-type mice. In bone marrow cells from middle-aged and old wild-type and Igf1r(+/-) male mice, palmitate inhibited osteoblast markers expression. In cells from young wild-type male mice, palmitate did not inhibit marker expression, but in cells from young male Igf1r(+/-) mice, palmitate inhibited bone sialoprotein and osterix but not osteocalcin or type I collagen (TIC). In female wild-type mice, palmitate inhibited osteoblast markers expression in cells from young, middle-aged, and old mice except TIC in cells from middle-aged mice. Palmitate inhibited bone sialoprotein expression in cells from middle-aged and old female Igf1r(+/-) mice and osteocalcin, osterix, and TIC expression in young and middle-aged female Igf1r(+/-) mice but stimulated expression in cells from old female Igf1r(+/-) mice. We conclude that IGF-1 receptor haploinsufficiency results in a prolipid accrual phenotype in bone in association with inhibition of growth factor-induced osteoblast differentiation, a situation which may phenocopy age-related decreases in bone formation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26076041      PMCID: PMC4511128          DOI: 10.1210/en.2014-1945

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

1.  The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2.

Authors:  J C Fleet; K Cashman; K Cox; V Rosen
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

2.  High fat diet induced insulin resistance and glucose intolerance are gender-specific in IGF-1R heterozygous mice.

Authors:  Neha Garg; Sachin Thakur; C Alex McMahan; Martin L Adamo
Journal:  Biochem Biophys Res Commun       Date:  2011-09-02       Impact factor: 3.575

3.  Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells.

Authors:  Lungile N N Shoba; John C Lee
Journal:  J Cell Biochem       Date:  2003-04-15       Impact factor: 4.429

4.  Protein kinase C (PKC) beta modulates serine phosphorylation of insulin receptor substrate-1 (IRS-1)--effect of overexpression of PKCbeta on insulin signal transduction.

Authors:  Tatsuo Ishizuka; Kazuo Kajita; Yoshiyuki Natsume; Yasunori Kawai; Yoshinori Kanoh; Atsushi Miura; Masayoshi Ishizawa; Yoshihiro Uno; Hiroyuki Morita; Keigo Yasuda
Journal:  Endocr Res       Date:  2004-05       Impact factor: 1.720

Review 5.  Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

Authors:  Anabela P Rolo; Carlos M Palmeira
Journal:  Toxicol Appl Pharmacol       Date:  2006-02-20       Impact factor: 4.219

6.  trans-10,cis-12 conjugated linoleic acid promotes bone formation by inhibiting adipogenesis by peroxisome proliferator activated receptor-γ-dependent mechanisms and by directly enhancing osteoblastogenesis from bone marrow mesenchymal stem cells.

Authors:  Jonggun Kim; Yooheon Park; Seong-Ho Lee; Yeonhwa Park
Journal:  J Nutr Biochem       Date:  2012-07-23       Impact factor: 6.048

7.  Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1.

Authors:  Klaus Moeschel; Alexander Beck; Cora Weigert; Reiner Lammers; Hubert Kalbacher; Wolfgang Voelter; Erwin D Schleicher; Hans-Ulrich Häring; Rainer Lehmann
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

8.  Liver-derived IGF-I regulates mean life span in mice.

Authors:  Johan Svensson; Klara Sjögren; Jenny Fäldt; Niklas Andersson; Olle Isaksson; John-Olov Jansson; Claes Ohlsson
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

Review 9.  IGF-1 and bone: New discoveries from mouse models.

Authors:  Shoshana Yakar; Hayden-William Courtland; David Clemmons
Journal:  J Bone Miner Res       Date:  2010-12       Impact factor: 6.741

10.  Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro.

Authors:  Alexandre Elbaz; Xiying Wu; Daniel Rivas; Jeffrey M Gimble; Gustavo Duque
Journal:  J Cell Mol Med       Date:  2009-03-27       Impact factor: 5.310

View more
  4 in total

Review 1.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

2.  Osteopenia in a Mouse Model of Spinal Cord Injury: Effects of Age, Sex and Motor Function.

Authors:  Michelle A Hook; Alyssa Falck; Ravali Dundumulla; Mabel Terminel; Rachel Cunningham; Arthur Sefiani; Kayla Callaway; Dana Gaddy; Cédric G Geoffroy
Journal:  Biology (Basel)       Date:  2022-01-26

Review 3.  Molecular Basis of Bone Aging.

Authors:  Addolorata Corrado; Daniela Cici; Cinzia Rotondo; Nicola Maruotti; Francesco Paolo Cantatore
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

4.  Revisiting the Debate: Does Exercise Build Strong Bones in the Mature and Senescent Skeleton?

Authors:  Julie M Hughes; Nisha Charkoudian; Jill N Barnes; Barbara J Morgan
Journal:  Front Physiol       Date:  2016-09-13       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.